DE60032250D1 - Behandlung von Allergien - Google Patents

Behandlung von Allergien

Info

Publication number
DE60032250D1
DE60032250D1 DE60032250T DE60032250T DE60032250D1 DE 60032250 D1 DE60032250 D1 DE 60032250D1 DE 60032250 T DE60032250 T DE 60032250T DE 60032250 T DE60032250 T DE 60032250T DE 60032250 D1 DE60032250 D1 DE 60032250D1
Authority
DE
Germany
Prior art keywords
medicament
treatment
derivative
allergies
allergenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60032250T
Other languages
English (en)
Other versions
DE60032250T2 (de
Inventor
Vera Dr Mahler
Susanne Dr Vrtala
Roland Dr Suck
Oliver Dr Cromwell
Helmut Dr Fiebig
Dietrich Dr Kraft
Rudolf Dr Valenta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomay AG
Original Assignee
Biomay AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170855&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60032250(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biomay AG filed Critical Biomay AG
Application granted granted Critical
Publication of DE60032250D1 publication Critical patent/DE60032250D1/de
Publication of DE60032250T2 publication Critical patent/DE60032250T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60032250T 2000-12-28 2000-12-28 Behandlung von Allergien Expired - Lifetime DE60032250T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00128661A EP1219300B1 (de) 2000-12-28 2000-12-28 Behandlung von Allergien

Publications (2)

Publication Number Publication Date
DE60032250D1 true DE60032250D1 (de) 2007-01-18
DE60032250T2 DE60032250T2 (de) 2007-03-15

Family

ID=8170855

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60032250T Expired - Lifetime DE60032250T2 (de) 2000-12-28 2000-12-28 Behandlung von Allergien

Country Status (6)

Country Link
US (1) US20020187158A1 (de)
EP (1) EP1219300B1 (de)
AT (1) ATE347376T1 (de)
DE (1) DE60032250T2 (de)
DK (1) DK1219300T3 (de)
HK (1) HK1045941B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030202980A1 (en) * 1995-12-29 2003-10-30 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
DE69940805D1 (de) * 1998-01-31 2009-06-10 Sinai School Medicine Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie
US7879977B2 (en) * 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
US8246945B2 (en) * 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
WO2001066136A2 (en) * 2000-04-06 2001-09-13 Panacea Pharmaceuticals, Llc. Microbial delivery system
EP1380290A1 (de) * 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht Cross-Beta-Strukturweg und seine therapeutische Relevanz
EP1663305A1 (de) * 2003-09-11 2006-06-07 Novozymes A/S Verfahren zur auswahl einer immuntherapeutischen zubereitung
CA2599218C (en) 2005-03-18 2015-08-11 Cytos Biotechnology Ag Cat allergen conjugates and uses thereof
CA2615078A1 (en) * 2005-07-13 2007-01-18 Crossbeta Biosciences B.V. Methods for determining the effect of a treatment on the cross-.beta. structure content of a protein; selection of treatments and uses thereof
EP1910844B1 (de) 2005-07-13 2012-04-18 Crossbeta Biosciences B.V. Cross-beta-struktur-bindende verbindungen
US8114832B2 (en) * 2005-07-13 2012-02-14 Crossbeta Biosciences B.V. Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
AT503297B1 (de) * 2006-05-18 2007-09-15 Biomay Ag Allergen-spezifische antikörper
US20080082584A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080082307A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
US10546652B2 (en) * 2006-09-29 2020-01-28 Gearbox Llc Computational systems for biomedical data
US20080082271A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
US10095836B2 (en) * 2006-09-29 2018-10-09 Gearbox Llc Computational systems for biomedical data
US20080082306A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
US20080091730A1 (en) * 2006-09-29 2008-04-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US10503872B2 (en) * 2006-09-29 2019-12-10 Gearbox Llc Computational systems for biomedical data
US7853626B2 (en) * 2006-09-29 2010-12-14 The Invention Science Fund I, Llc Computational systems for biomedical data
US20080082583A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US10068303B2 (en) * 2006-09-29 2018-09-04 Gearbox Llc Computational systems for biomedical data
US20080109484A1 (en) * 2006-09-29 2008-05-08 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080082364A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080082359A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of State Of Delaware Computational systems for biomedical data
US20080082367A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US8122073B2 (en) * 2006-09-29 2012-02-21 The Invention Science Fund I Computational systems for biomedical data
EP2058000A1 (de) * 2007-11-08 2009-05-13 Crossbeta Biosciences B.V. Zur Aktivierung von T-Zellen fähige immunogene Zusammensetzung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187311B1 (en) * 1995-03-28 2001-02-13 Asahi Breweries, Ltd. Engineered acarid allergen and process for producing the same
SE9703531D0 (sv) * 1997-09-30 1997-09-30 Rudolf Valenta Non-anaphlactic forms of allergens and their use
DK1062341T3 (da) * 1998-03-16 2008-11-03 Alk Abello As Muterede rekombinante allergener
US6123456A (en) * 1998-07-01 2000-09-26 General Electric Company Catalytic hydrogenation to remove gas from x-ray tube cooling oil

Also Published As

Publication number Publication date
EP1219300B1 (de) 2006-12-06
EP1219300A1 (de) 2002-07-03
US20020187158A1 (en) 2002-12-12
DK1219300T3 (da) 2007-03-05
DE60032250T2 (de) 2007-03-15
ATE347376T1 (de) 2006-12-15
HK1045941B (zh) 2007-06-29
HK1045941A1 (en) 2002-12-20

Similar Documents

Publication Publication Date Title
ATE347376T1 (de) Behandlung von allergien
EA200000608A1 (ru) Предотвращение и лечение амилоидогенного заболевания
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
CY1110727T1 (el) Παρασκευασματα θετικων κατα gram βακτηριων για τη θεραπεια ασθενειων που περιλαμβανουν μια ανοσολογικη δυσρυθμιση
CY1107550T1 (el) Συνδυαστικα εμβολια μηνιγγιτιδας b/c
ATE495755T1 (de) Vorbeugung und behandlung von amyloidogenischen krankheiten
DK1151009T3 (da) Antimikrobielt/endotoksin-neutraliserende polypeptid
NO20022531L (no) Vaksine for forebyggelse og behandling av Alzheimer- og amyloidrelaterte sykdommer
PT1040830E (pt) Medicamento para doencas neurodegenerativas
DE69718150D1 (de) Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien
DE60231131D1 (de) Vakzine und verwendung davon zur behandlung amyotrophischer lateralsklerose
CY1105545T1 (el) Θεραπεια στατινης για ενισχυση της διατηρησης νοητικης λειτουργιας
DE59605959D1 (de) Verwendung von Immunglobulin-Präparationen zur Herstellung eines Medikaments zur oralen Verabreichung zur Behandlung und Prophylaxe chronischer Schmerzzustände
DK0588477T3 (da) Medicinsk præparat omfatende TCF-11
DE69326627D1 (de) Therapeutisches Mittel gegen drohenden Abortus
DE60138385D1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
BR0311180A (pt) Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos
DE60234031D1 (de) Mittel zur behandlung allergischer augenerkrankungen
DK0865284T3 (da) Præparater, som indeholder vismut og ét eller flere antimikrobiske midler, til forebyggelse og behandling af gastrointestinale sygdomme
DE69421705D1 (de) Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen
ATE107504T1 (de) Arzneimittel zur behandlung von kryptosporidiose.
ATE212229T1 (de) Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden
DK0865287T3 (da) Præparater indeholdende bismuth til forebyggelse og behandling af gastrointestinale lidelser
RU2001124669A (ru) Способ профилактики паратифа телят
RU2002130727A (ru) Способ лечения детей и подростков с латентной туберкулезной инфекцией

Legal Events

Date Code Title Description
8363 Opposition against the patent